Peptide United

Research Tool

Compare Peptides

Select two peptides to view a side-by-side breakdown of their profiles, mechanisms, and research data.

Semax

MEHFPGP · Pro8-Gly9-Pro10-ACTH(4–10)

Research Status
Approved
Approved
Half-Life
~5–10 minutes in serum; nasal effects last 1–3 hours
~20 minutes (active metabolite activity is prolonged)
Mol. Weight
751.87 Da
Admin Routes
intranasal, subcutaneous
intranasal, subcutaneous
Categories
Cognitive Enhancement, Immune Support
Cognitive Enhancement, Neuroprotection
Interaction
additive

Selank exerts anxiolytic and immunomodulatory effects primarily through GABA-A modulation and BDNF upregulation, while semax predominantly drives cognitive enhancement via BDNF and dopaminergic pathways. Overlapping BDNF activity suggests additive nootropic potential.

emerging

Mechanism
Pharmacokinetics
Research Findings
Safety